nodes	percent_of_prediction	percent_of_DWPC	metapath
Cladribine—ABCG2—Leflunomide—systemic lupus erythematosus	0.124	0.319	CbGbCtD
Cladribine—ABCG2—Mycophenolate mofetil—systemic lupus erythematosus	0.0766	0.197	CbGbCtD
Cladribine—ABCG2—Hydrocortisone—systemic lupus erythematosus	0.0615	0.158	CbGbCtD
Cladribine—ABCG2—Cyclosporine—systemic lupus erythematosus	0.058	0.149	CbGbCtD
Cladribine—ABCG2—Dexamethasone—systemic lupus erythematosus	0.0382	0.0982	CbGbCtD
Cladribine—ABCG2—Methotrexate—systemic lupus erythematosus	0.0307	0.079	CbGbCtD
Cladribine—PNP—blood plasma—systemic lupus erythematosus	0.00795	0.0468	CbGeAlD
Cladribine—POLE4—skin of body—systemic lupus erythematosus	0.00692	0.0407	CbGeAlD
Cladribine—POLE2—tendon—systemic lupus erythematosus	0.0046	0.0271	CbGeAlD
Cladribine—POLE2—bone marrow—systemic lupus erythematosus	0.00446	0.0263	CbGeAlD
Cladribine—POLE4—nervous system—systemic lupus erythematosus	0.00428	0.0252	CbGeAlD
Cladribine—POLE4—central nervous system—systemic lupus erythematosus	0.00412	0.0243	CbGeAlD
Cladribine—POLE2—lung—systemic lupus erythematosus	0.00404	0.0238	CbGeAlD
Cladribine—RRM2B—connective tissue—systemic lupus erythematosus	0.00393	0.0232	CbGeAlD
Cladribine—PNP—kidney—systemic lupus erythematosus	0.0036	0.0212	CbGeAlD
Cladribine—POLE3—nephron tubule—systemic lupus erythematosus	0.0036	0.0212	CbGeAlD
Cladribine—RRM2B—cortex of kidney—systemic lupus erythematosus	0.00326	0.0192	CbGeAlD
Cladribine—POLE3—kidney—systemic lupus erythematosus	0.00316	0.0186	CbGeAlD
Cladribine—PNP—lymphoid tissue—systemic lupus erythematosus	0.0031	0.0182	CbGeAlD
Cladribine—POLE3—cortex of kidney—systemic lupus erythematosus	0.00308	0.0181	CbGeAlD
Cladribine—PNP—bone marrow—systemic lupus erythematosus	0.00282	0.0166	CbGeAlD
Cladribine—POLE3—lymphoid tissue—systemic lupus erythematosus	0.00272	0.016	CbGeAlD
Cladribine—RRM2B—tendon—systemic lupus erythematosus	0.0027	0.0159	CbGeAlD
Cladribine—NR5A1—lymphoid tissue—systemic lupus erythematosus	0.00263	0.0155	CbGeAlD
Cladribine—RRM2B—bone marrow—systemic lupus erythematosus	0.00262	0.0154	CbGeAlD
Cladribine—PNP—lung—systemic lupus erythematosus	0.00255	0.015	CbGeAlD
Cladribine—POLE3—tendon—systemic lupus erythematosus	0.00255	0.015	CbGeAlD
Cladribine—POLE3—bone marrow—systemic lupus erythematosus	0.00247	0.0146	CbGeAlD
Cladribine—RRM2B—lung—systemic lupus erythematosus	0.00237	0.014	CbGeAlD
Cladribine—PNP—nervous system—systemic lupus erythematosus	0.00237	0.0139	CbGeAlD
Cladribine—POLE—cortex of kidney—systemic lupus erythematosus	0.00235	0.0138	CbGeAlD
Cladribine—SLC28A3—bone marrow—systemic lupus erythematosus	0.00232	0.0136	CbGeAlD
Cladribine—PNP—central nervous system—systemic lupus erythematosus	0.00228	0.0134	CbGeAlD
Cladribine—POLE3—lung—systemic lupus erythematosus	0.00224	0.0132	CbGeAlD
Cladribine—RRM2B—nervous system—systemic lupus erythematosus	0.0022	0.0129	CbGeAlD
Cladribine—RRM2B—central nervous system—systemic lupus erythematosus	0.00211	0.0125	CbGeAlD
Cladribine—RRM2—skin of body—systemic lupus erythematosus	0.00211	0.0124	CbGeAlD
Cladribine—SLC28A3—lung—systemic lupus erythematosus	0.0021	0.0124	CbGeAlD
Cladribine—POLE3—nervous system—systemic lupus erythematosus	0.00208	0.0122	CbGeAlD
Cladribine—POLE—lymphoid tissue—systemic lupus erythematosus	0.00207	0.0122	CbGeAlD
Cladribine—NR5A1—nervous system—systemic lupus erythematosus	0.00201	0.0118	CbGeAlD
Cladribine—POLE3—central nervous system—systemic lupus erythematosus	0.002	0.0118	CbGeAlD
Cladribine—RRM2—kidney—systemic lupus erythematosus	0.00199	0.0117	CbGeAlD
Cladribine—POLE—tendon—systemic lupus erythematosus	0.00195	0.0115	CbGeAlD
Cladribine—NR5A1—central nervous system—systemic lupus erythematosus	0.00194	0.0114	CbGeAlD
Cladribine—POLE—bone marrow—systemic lupus erythematosus	0.00189	0.0111	CbGeAlD
Cladribine—RRM1—nephron tubule—systemic lupus erythematosus	0.00188	0.0111	CbGeAlD
Cladribine—SLC22A2—nephron tubule—systemic lupus erythematosus	0.00176	0.0104	CbGeAlD
Cladribine—RRM1—skin of body—systemic lupus erythematosus	0.00175	0.0103	CbGeAlD
Cladribine—POLE—lung—systemic lupus erythematosus	0.00171	0.0101	CbGeAlD
Cladribine—RRM2—lymphoid tissue—systemic lupus erythematosus	0.00171	0.0101	CbGeAlD
Cladribine—POLA1—tendon—systemic lupus erythematosus	0.00168	0.00989	CbGeAlD
Cladribine—RRM1—kidney—systemic lupus erythematosus	0.00165	0.00972	CbGeAlD
Cladribine—POLA1—bone marrow—systemic lupus erythematosus	0.00163	0.00958	CbGeAlD
Cladribine—RRM1—cortex of kidney—systemic lupus erythematosus	0.00161	0.00947	CbGeAlD
Cladribine—RRM2—tendon—systemic lupus erythematosus	0.0016	0.00945	CbGeAlD
Cladribine—POLE—nervous system—systemic lupus erythematosus	0.00158	0.00933	CbGeAlD
Cladribine—RRM2—bone marrow—systemic lupus erythematosus	0.00155	0.00915	CbGeAlD
Cladribine—SLC22A2—kidney—systemic lupus erythematosus	0.00155	0.00912	CbGeAlD
Cladribine—POLE—central nervous system—systemic lupus erythematosus	0.00152	0.00898	CbGeAlD
Cladribine—SLC22A2—cortex of kidney—systemic lupus erythematosus	0.00151	0.00888	CbGeAlD
Cladribine—POLA1—lung—systemic lupus erythematosus	0.00147	0.00868	CbGeAlD
Cladribine—DCK—nephron tubule—systemic lupus erythematosus	0.00146	0.00859	CbGeAlD
Cladribine—RRM1—lymphoid tissue—systemic lupus erythematosus	0.00142	0.00835	CbGeAlD
Cladribine—RRM2—lung—systemic lupus erythematosus	0.00141	0.00829	CbGeAlD
Cladribine—RRM1—tendon—systemic lupus erythematosus	0.00133	0.00785	CbGeAlD
Cladribine—RRM2—nervous system—systemic lupus erythematosus	0.0013	0.00768	CbGeAlD
Cladribine—RRM1—bone marrow—systemic lupus erythematosus	0.00129	0.0076	CbGeAlD
Cladribine—RRM2—central nervous system—systemic lupus erythematosus	0.00126	0.00739	CbGeAlD
Cladribine—DCK—cortex of kidney—systemic lupus erythematosus	0.00125	0.00736	CbGeAlD
Cladribine—RRM1—lung—systemic lupus erythematosus	0.00117	0.00689	CbGeAlD
Cladribine—DCK—lymphoid tissue—systemic lupus erythematosus	0.0011	0.00649	CbGeAlD
Cladribine—SLC22A1—kidney—systemic lupus erythematosus	0.00109	0.00644	CbGeAlD
Cladribine—RRM1—nervous system—systemic lupus erythematosus	0.00108	0.00638	CbGeAlD
Cladribine—RRM1—central nervous system—systemic lupus erythematosus	0.00104	0.00614	CbGeAlD
Cladribine—DCK—tendon—systemic lupus erythematosus	0.00104	0.0061	CbGeAlD
Cladribine—DCK—bone marrow—systemic lupus erythematosus	0.001	0.00591	CbGeAlD
Cladribine—POLE2—Retinoblastoma (RB) in Cancer—HMGB1—systemic lupus erythematosus	0.000942	0.00832	CbGpPWpGaD
Cladribine—NR5A1—Ovarian Infertility Genes—CDKN1B—systemic lupus erythematosus	0.000918	0.00811	CbGpPWpGaD
Cladribine—SLC28A3—Transport of vitamins, nucleosides, and related molecules—ALB—systemic lupus erythematosus	0.000916	0.00809	CbGpPWpGaD
Cladribine—DCK—lung—systemic lupus erythematosus	0.000909	0.00535	CbGeAlD
Cladribine—NR5A1—Nuclear Receptor transcription pathway—PPARG—systemic lupus erythematosus	0.000849	0.0075	CbGpPWpGaD
Cladribine—RRM2B—Direct p53 effectors—VDR—systemic lupus erythematosus	0.000842	0.00744	CbGpPWpGaD
Cladribine—DCK—nervous system—systemic lupus erythematosus	0.000841	0.00496	CbGeAlD
Cladribine—ABCG2—nephron tubule—systemic lupus erythematosus	0.000814	0.00479	CbGeAlD
Cladribine—DCK—central nervous system—systemic lupus erythematosus	0.00081	0.00477	CbGeAlD
Cladribine—POLE—Chromosome Maintenance—HIST2H2AC—systemic lupus erythematosus	0.000795	0.00702	CbGpPWpGaD
Cladribine—POLE—G1 to S cell cycle control—GADD45A—systemic lupus erythematosus	0.000789	0.00697	CbGpPWpGaD
Cladribine—RRM2B—DNA Damage Response—CDKN1B—systemic lupus erythematosus	0.00078	0.00689	CbGpPWpGaD
Cladribine—RRM1—Retinoblastoma (RB) in Cancer—HMGB1—systemic lupus erythematosus	0.000768	0.00678	CbGpPWpGaD
Cladribine—RRM2B—miRNA Regulation of DNA Damage Response—CDKN1B—systemic lupus erythematosus	0.000753	0.00665	CbGpPWpGaD
Cladribine—RRM2B—Direct p53 effectors—FAS—systemic lupus erythematosus	0.000735	0.00649	CbGpPWpGaD
Cladribine—RRM2B—DNA Damage Response—CDKN1A—systemic lupus erythematosus	0.000719	0.00636	CbGpPWpGaD
Cladribine—SLC22A1—nervous system—systemic lupus erythematosus	0.000718	0.00423	CbGeAlD
Cladribine—RRM2B—miRNA Regulation of DNA Damage Response—CDKN1A—systemic lupus erythematosus	0.000695	0.00614	CbGpPWpGaD
Cladribine—SLC28A3—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.000691	0.00611	CbGpPWpGaD
Cladribine—SLC22A1—central nervous system—systemic lupus erythematosus	0.000691	0.00407	CbGeAlD
Cladribine—POLA1—Telomere Maintenance—HIST2H2AC—systemic lupus erythematosus	0.00068	0.006	CbGpPWpGaD
Cladribine—RRM2—Retinoblastoma (RB) in Cancer—HMGB1—systemic lupus erythematosus	0.000632	0.00559	CbGpPWpGaD
Cladribine—ABCG2—HIF-2-alpha transcription factor network—ETS1—systemic lupus erythematosus	0.000627	0.00554	CbGpPWpGaD
Cladribine—POLE—Retinoblastoma (RB) in Cancer—HMGB1—systemic lupus erythematosus	0.000607	0.00536	CbGpPWpGaD
Cladribine—DCK—Retinoblastoma (RB) in Cancer—HMGB1—systemic lupus erythematosus	0.000591	0.00522	CbGpPWpGaD
Cladribine—POLA1—Chromosome Maintenance—HIST2H2AC—systemic lupus erythematosus	0.000566	0.005	CbGpPWpGaD
Cladribine—ABCG2—bone marrow—systemic lupus erythematosus	0.000559	0.0033	CbGeAlD
Cladribine—ABCG2—lung—systemic lupus erythematosus	0.000507	0.00299	CbGeAlD
Cladribine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—LYN—systemic lupus erythematosus	0.000477	0.00422	CbGpPWpGaD
Cladribine—POLE2—G1 to S cell cycle control—CDKN1B—systemic lupus erythematosus	0.000476	0.00421	CbGpPWpGaD
Cladribine—POLE2—Mitotic M-M/G1 phases—HIST2H2AC—systemic lupus erythematosus	0.000468	0.00413	CbGpPWpGaD
Cladribine—POLE2—G1 to S cell cycle control—CDKN1A—systemic lupus erythematosus	0.00044	0.00388	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	0.000437	0.00386	CbGpPWpGaD
Cladribine—POLA1—Retinoblastoma (RB) in Cancer—HMGB1—systemic lupus erythematosus	0.000432	0.00382	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	0.000412	0.00364	CbGpPWpGaD
Cladribine—RRM2B—Direct p53 effectors—CDKN1A—systemic lupus erythematosus	0.000404	0.00357	CbGpPWpGaD
Cladribine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—systemic lupus erythematosus	0.0004	0.00353	CbGpPWpGaD
Cladribine—POLE2—Retinoblastoma (RB) in Cancer—CDKN1B—systemic lupus erythematosus	0.000391	0.00346	CbGpPWpGaD
Cladribine—RRM2B—Direct p53 effectors—EP300—systemic lupus erythematosus	0.000384	0.00339	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—SNRPD1—systemic lupus erythematosus	0.000384	0.00339	CbGpPWpGaD
Cladribine—ABCG2—HIF-1-alpha transcription factor network—ETS1—systemic lupus erythematosus	0.000369	0.00326	CbGpPWpGaD
Cladribine—RRM1—E2F transcription factor network—CDKN1B—systemic lupus erythematosus	0.000367	0.00324	CbGpPWpGaD
Cladribine—POLE2—Synthesis of DNA—CDKN1B—systemic lupus erythematosus	0.000361	0.00319	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	0.000361	0.00319	CbGpPWpGaD
Cladribine—POLE2—Retinoblastoma (RB) in Cancer—CDKN1A—systemic lupus erythematosus	0.000361	0.00319	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle, Mitotic—HIST2H2AC—systemic lupus erythematosus	0.00035	0.00309	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—MTA2—systemic lupus erythematosus	0.000347	0.00307	CbGpPWpGaD
Cladribine—POLE2—DNA Replication—CDKN1B—systemic lupus erythematosus	0.000339	0.003	CbGpPWpGaD
Cladribine—RRM1—E2F transcription factor network—CDKN1A—systemic lupus erythematosus	0.000339	0.00299	CbGpPWpGaD
Cladribine—SLC22A2—SLC-mediated transmembrane transport—SLC15A4—systemic lupus erythematosus	0.000338	0.00299	CbGpPWpGaD
Cladribine—POLE2—Synthesis of DNA—CDKN1A—systemic lupus erythematosus	0.000334	0.00295	CbGpPWpGaD
Cladribine—POLE2—G1/S Transition—CDKN1B—systemic lupus erythematosus	0.000327	0.00288	CbGpPWpGaD
Cladribine—RRM1—E2F transcription factor network—EP300—systemic lupus erythematosus	0.000322	0.00285	CbGpPWpGaD
Cladribine—RRM1—Retinoblastoma (RB) in Cancer—CDKN1B—systemic lupus erythematosus	0.000319	0.00282	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—LYN—systemic lupus erythematosus	0.000316	0.00279	CbGpPWpGaD
Cladribine—SLC22A1—SLC-mediated transmembrane transport—SLC15A4—systemic lupus erythematosus	0.000315	0.00278	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—HIST2H2AC—systemic lupus erythematosus	0.000313	0.00276	CbGpPWpGaD
Cladribine—POLE2—DNA Replication—CDKN1A—systemic lupus erythematosus	0.000313	0.00276	CbGpPWpGaD
Cladribine—POLE—G1 to S cell cycle control—CDKN1B—systemic lupus erythematosus	0.000307	0.00271	CbGpPWpGaD
Cladribine—ABCG2—HIF-1-alpha transcription factor network—CXCL12—systemic lupus erythematosus	0.000303	0.00267	CbGpPWpGaD
Cladribine—RRM2—E2F transcription factor network—CDKN1B—systemic lupus erythematosus	0.000302	0.00267	CbGpPWpGaD
Cladribine—POLE—Mitotic M-M/G1 phases—HIST2H2AC—systemic lupus erythematosus	0.000302	0.00266	CbGpPWpGaD
Cladribine—POLE2—G1/S Transition—CDKN1A—systemic lupus erythematosus	0.000301	0.00266	CbGpPWpGaD
Cladribine—POLE2—S Phase—CDKN1B—systemic lupus erythematosus	0.000296	0.00262	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	0.000296	0.00261	CbGpPWpGaD
Cladribine—RRM1—Retinoblastoma (RB) in Cancer—CDKN1A—systemic lupus erythematosus	0.000294	0.0026	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	0.000285	0.00252	CbGpPWpGaD
Cladribine—POLE—G1 to S cell cycle control—CDKN1A—systemic lupus erythematosus	0.000283	0.0025	CbGpPWpGaD
Cladribine—RRM2—E2F transcription factor network—CDKN1A—systemic lupus erythematosus	0.000279	0.00246	CbGpPWpGaD
Cladribine—POLE2—Mitotic G1-G1/S phases—CDKN1B—systemic lupus erythematosus	0.000275	0.00243	CbGpPWpGaD
Cladribine—POLE2—S Phase—CDKN1A—systemic lupus erythematosus	0.000274	0.00242	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—PTPRC—systemic lupus erythematosus	0.00027	0.00239	CbGpPWpGaD
Cladribine—RRM2—E2F transcription factor network—EP300—systemic lupus erythematosus	0.000265	0.00234	CbGpPWpGaD
Cladribine—NR5A1—Generic Transcription Pathway—JUNB—systemic lupus erythematosus	0.000265	0.00234	CbGpPWpGaD
Cladribine—RRM2—Retinoblastoma (RB) in Cancer—CDKN1B—systemic lupus erythematosus	0.000263	0.00232	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—ADIPOQ—systemic lupus erythematosus	0.000255	0.00225	CbGpPWpGaD
Cladribine—POLE2—Mitotic G1-G1/S phases—CDKN1A—systemic lupus erythematosus	0.000254	0.00224	CbGpPWpGaD
Cladribine—PNP—Flunisolide—Hydrocortisone—systemic lupus erythematosus	0.000253	0.0316	CbGdCrCtD
Cladribine—POLE—Retinoblastoma (RB) in Cancer—CDKN1B—systemic lupus erythematosus	0.000252	0.00223	CbGpPWpGaD
Cladribine—POLA1—Norethindrone—Hydrocortisone—systemic lupus erythematosus	0.000247	0.0309	CbGdCrCtD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	0.000246	0.00218	CbGpPWpGaD
Cladribine—DCK—Retinoblastoma (RB) in Cancer—CDKN1B—systemic lupus erythematosus	0.000245	0.00217	CbGpPWpGaD
Cladribine—RRM2—Retinoblastoma (RB) in Cancer—CDKN1A—systemic lupus erythematosus	0.000242	0.00214	CbGpPWpGaD
Cladribine—PNP—Clobetasol propionate—Methylprednisolone—systemic lupus erythematosus	0.000241	0.0302	CbGdCrCtD
Cladribine—RRM2B—Metabolism—NAT2—systemic lupus erythematosus	0.000241	0.00213	CbGpPWpGaD
Cladribine—PNP—Flunisolide—Methylprednisolone—systemic lupus erythematosus	0.000238	0.0298	CbGdCrCtD
Cladribine—PNP—Clobetasol propionate—Betamethasone—systemic lupus erythematosus	0.000238	0.0297	CbGdCrCtD
Cladribine—PNP—Clobetasol propionate—Dexamethasone—systemic lupus erythematosus	0.000238	0.0297	CbGdCrCtD
Cladribine—RRM2—Cell Cycle, Mitotic—HIST2H2AC—systemic lupus erythematosus	0.000235	0.00208	CbGpPWpGaD
Cladribine—PNP—Flunisolide—Betamethasone—systemic lupus erythematosus	0.000235	0.0293	CbGdCrCtD
Cladribine—PNP—Flunisolide—Dexamethasone—systemic lupus erythematosus	0.000235	0.0293	CbGdCrCtD
Cladribine—NR5A1—Gene Expression—TNFSF13—systemic lupus erythematosus	0.000235	0.00207	CbGpPWpGaD
Cladribine—POLE—Synthesis of DNA—CDKN1B—systemic lupus erythematosus	0.000233	0.00206	CbGpPWpGaD
Cladribine—PNP—Testosterone Propionate—Hydrocortisone—systemic lupus erythematosus	0.000233	0.0291	CbGdCrCtD
Cladribine—POLE—Retinoblastoma (RB) in Cancer—CDKN1A—systemic lupus erythematosus	0.000233	0.00205	CbGpPWpGaD
Cladribine—PNP—Clobetasol propionate—Triamcinolone—systemic lupus erythematosus	0.000232	0.029	CbGdCrCtD
Cladribine—NR5A1—Generic Transcription Pathway—RXRA—systemic lupus erythematosus	0.000232	0.00205	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	0.000232	0.00205	CbGpPWpGaD
Cladribine—PNP—Fluticasone Propionate—Methylprednisolone—systemic lupus erythematosus	0.00023	0.0288	CbGdCrCtD
Cladribine—PNP—Flunisolide—Triamcinolone—systemic lupus erythematosus	0.000229	0.0286	CbGdCrCtD
Cladribine—NR5A1—Gene Expression—SNRPB—systemic lupus erythematosus	0.000227	0.00201	CbGpPWpGaD
Cladribine—PNP—Fluticasone Propionate—Betamethasone—systemic lupus erythematosus	0.000226	0.0283	CbGdCrCtD
Cladribine—PNP—Fluticasone Propionate—Dexamethasone—systemic lupus erythematosus	0.000226	0.0283	CbGdCrCtD
Cladribine—DCK—Retinoblastoma (RB) in Cancer—CDKN1A—systemic lupus erythematosus	0.000226	0.002	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—HIST2H2AC—systemic lupus erythematosus	0.000226	0.00199	CbGpPWpGaD
Cladribine—PNP—Fluticasone Propionate—Triamcinolone—systemic lupus erythematosus	0.000221	0.0277	CbGdCrCtD
Cladribine—PNP—Clobetasol propionate—Prednisone—systemic lupus erythematosus	0.00022	0.0275	CbGdCrCtD
Cladribine—RRM2—G1/S Transition—CDKN1B—systemic lupus erythematosus	0.000219	0.00194	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—RXRA—systemic lupus erythematosus	0.000219	0.00193	CbGpPWpGaD
Cladribine—POLE—DNA Replication—CDKN1B—systemic lupus erythematosus	0.000218	0.00193	CbGpPWpGaD
Cladribine—PNP—Flunisolide—Prednisone—systemic lupus erythematosus	0.000218	0.0272	CbGdCrCtD
Cladribine—PNP—Fluocinolone Acetonide—Methylprednisolone—systemic lupus erythematosus	0.000217	0.0271	CbGdCrCtD
Cladribine—PNP—Clobetasol propionate—Prednisolone—systemic lupus erythematosus	0.000215	0.0269	CbGdCrCtD
Cladribine—POLE—Synthesis of DNA—CDKN1A—systemic lupus erythematosus	0.000215	0.0019	CbGpPWpGaD
Cladribine—POLA1—Mitotic M-M/G1 phases—HIST2H2AC—systemic lupus erythematosus	0.000215	0.0019	CbGpPWpGaD
Cladribine—PNP—Fluocinolone Acetonide—Betamethasone—systemic lupus erythematosus	0.000213	0.0267	CbGdCrCtD
Cladribine—PNP—Fluocinolone Acetonide—Dexamethasone—systemic lupus erythematosus	0.000213	0.0267	CbGdCrCtD
Cladribine—PNP—Flunisolide—Prednisolone—systemic lupus erythematosus	0.000212	0.0265	CbGdCrCtD
Cladribine—POLE—G1/S Transition—CDKN1B—systemic lupus erythematosus	0.00021	0.00186	CbGpPWpGaD
Cladribine—NR5A1—Generic Transcription Pathway—VDR—systemic lupus erythematosus	0.00021	0.00186	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—HIST2H2AC—systemic lupus erythematosus	0.00021	0.00186	CbGpPWpGaD
Cladribine—PNP—Metabolism—NAT2—systemic lupus erythematosus	0.000209	0.00184	CbGpPWpGaD
Cladribine—PNP—Fluocinolone Acetonide—Triamcinolone—systemic lupus erythematosus	0.000208	0.0261	CbGdCrCtD
Cladribine—POLA1—E2F transcription factor network—CDKN1B—systemic lupus erythematosus	0.000207	0.00183	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	0.000203	0.0018	CbGpPWpGaD
Cladribine—RRM2—G1/S Transition—CDKN1A—systemic lupus erythematosus	0.000202	0.00179	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—HIST2H2AC—systemic lupus erythematosus	0.000202	0.00178	CbGpPWpGaD
Cladribine—POLE—DNA Replication—CDKN1A—systemic lupus erythematosus	0.000202	0.00178	CbGpPWpGaD
Cladribine—POLA1—Levonorgestrel—Hydrocortisone—systemic lupus erythematosus	0.000197	0.0246	CbGdCrCtD
Cladribine—SLC28A3—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	0.000197	0.00174	CbGpPWpGaD
Cladribine—POLE—G1/S Transition—CDKN1A—systemic lupus erythematosus	0.000194	0.00172	CbGpPWpGaD
Cladribine—PNP—Danazol—Hydrocortisone—systemic lupus erythematosus	0.000194	0.0242	CbGdCrCtD
Cladribine—PNP—Fluocinolone Acetonide—Prednisolone—systemic lupus erythematosus	0.000193	0.0241	CbGdCrCtD
Cladribine—POLE—S Phase—CDKN1B—systemic lupus erythematosus	0.000191	0.00169	CbGpPWpGaD
Cladribine—POLA1—E2F transcription factor network—CDKN1A—systemic lupus erythematosus	0.000191	0.00168	CbGpPWpGaD
Cladribine—NR5A1—Generic Transcription Pathway—NR3C1—systemic lupus erythematosus	0.000189	0.00167	CbGpPWpGaD
Cladribine—RRM2—Mitotic G1-G1/S phases—CDKN1B—systemic lupus erythematosus	0.000185	0.00163	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—JAK1—systemic lupus erythematosus	0.000184	0.00162	CbGpPWpGaD
Cladribine—ABCG2—HIF-2-alpha transcription factor network—EP300—systemic lupus erythematosus	0.000183	0.00162	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—HIST2H2AC—systemic lupus erythematosus	0.000182	0.00161	CbGpPWpGaD
Cladribine—POLA1—E2F transcription factor network—EP300—systemic lupus erythematosus	0.000181	0.0016	CbGpPWpGaD
Cladribine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1B—systemic lupus erythematosus	0.00018	0.00159	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	0.000179	0.00159	CbGpPWpGaD
Cladribine—POLE—Mitotic G1-G1/S phases—CDKN1B—systemic lupus erythematosus	0.000177	0.00157	CbGpPWpGaD
Cladribine—POLE—S Phase—CDKN1A—systemic lupus erythematosus	0.000176	0.00156	CbGpPWpGaD
Cladribine—SLC28A3—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	0.000176	0.00155	CbGpPWpGaD
Cladribine—PNP—Norethindrone—Hydrocortisone—systemic lupus erythematosus	0.000174	0.0218	CbGdCrCtD
Cladribine—ABCG2—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.000174	0.00153	CbGpPWpGaD
Cladribine—ABCG2—HIF-2-alpha transcription factor network—VEGFA—systemic lupus erythematosus	0.000173	0.00153	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.000172	0.00152	CbGpPWpGaD
Cladribine—RRM2—Mitotic G1-G1/S phases—CDKN1A—systemic lupus erythematosus	0.00017	0.00151	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	0.00017	0.0015	CbGpPWpGaD
Cladribine—PNP—Danazol—Prednisone—systemic lupus erythematosus	0.000167	0.0208	CbGdCrCtD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	0.000167	0.00147	CbGpPWpGaD
Cladribine—POLA1—Synthesis of DNA—CDKN1B—systemic lupus erythematosus	0.000166	0.00147	CbGpPWpGaD
Cladribine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1A—systemic lupus erythematosus	0.000166	0.00146	CbGpPWpGaD
Cladribine—Urticaria—Cyclosporine—systemic lupus erythematosus	0.000165	0.000515	CcSEcCtD
Cladribine—Myalgia—Dexamethasone—systemic lupus erythematosus	0.000164	0.000514	CcSEcCtD
Cladribine—Myalgia—Betamethasone—systemic lupus erythematosus	0.000164	0.000514	CcSEcCtD
Cladribine—Body temperature increased—Cyclosporine—systemic lupus erythematosus	0.000164	0.000513	CcSEcCtD
Cladribine—Abdominal pain—Cyclosporine—systemic lupus erythematosus	0.000164	0.000513	CcSEcCtD
Cladribine—Anxiety—Dexamethasone—systemic lupus erythematosus	0.000164	0.000512	CcSEcCtD
Cladribine—Anxiety—Betamethasone—systemic lupus erythematosus	0.000164	0.000512	CcSEcCtD
Cladribine—POLE—Mitotic G1-G1/S phases—CDKN1A—systemic lupus erythematosus	0.000164	0.00145	CbGpPWpGaD
Cladribine—Discomfort—Betamethasone—systemic lupus erythematosus	0.000162	0.000507	CcSEcCtD
Cladribine—Discomfort—Dexamethasone—systemic lupus erythematosus	0.000162	0.000507	CcSEcCtD
Cladribine—Haemoglobin—Methotrexate—systemic lupus erythematosus	0.000162	0.000507	CcSEcCtD
Cladribine—Hypotension—Methylprednisolone—systemic lupus erythematosus	0.000162	0.000506	CcSEcCtD
Cladribine—Pain—Prednisolone—systemic lupus erythematosus	0.000161	0.000504	CcSEcCtD
Cladribine—Haemorrhage—Methotrexate—systemic lupus erythematosus	0.000161	0.000504	CcSEcCtD
Cladribine—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	0.000161	0.000502	CcSEcCtD
Cladribine—POLA1—Cell Cycle, Mitotic—HIST2H2AC—systemic lupus erythematosus	0.000161	0.00142	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	0.000161	0.00142	CbGpPWpGaD
Cladribine—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.00016	0.000501	CcSEcCtD
Cladribine—Pharyngitis—Methotrexate—systemic lupus erythematosus	0.00016	0.000501	CcSEcCtD
Cladribine—SLC22A1—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	0.00016	0.00141	CbGpPWpGaD
Cladribine—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	0.00016	0.0005	CcSEcCtD
Cladribine—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.00016	0.0005	CcSEcCtD
Cladribine—Nausea—Leflunomide—systemic lupus erythematosus	0.00016	0.000499	CcSEcCtD
Cladribine—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	0.000159	0.000498	CcSEcCtD
Cladribine—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000159	0.000497	CcSEcCtD
Cladribine—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.000159	0.000497	CcSEcCtD
Cladribine—Urethral disorder—Methotrexate—systemic lupus erythematosus	0.000158	0.000494	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	0.000158	0.000494	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	0.000158	0.000493	CcSEcCtD
Cladribine—Pain—Hydrocortisone—systemic lupus erythematosus	0.000158	0.000493	CcSEcCtD
Cladribine—Oedema—Betamethasone—systemic lupus erythematosus	0.000158	0.000492	CcSEcCtD
Cladribine—Oedema—Dexamethasone—systemic lupus erythematosus	0.000158	0.000492	CcSEcCtD
Cladribine—Insomnia—Triamcinolone—systemic lupus erythematosus	0.000157	0.000491	CcSEcCtD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	0.000157	0.00139	CbGpPWpGaD
Cladribine—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.000157	0.00049	CcSEcCtD
Cladribine—Infection—Dexamethasone—systemic lupus erythematosus	0.000157	0.000489	CcSEcCtD
Cladribine—Infection—Betamethasone—systemic lupus erythematosus	0.000157	0.000489	CcSEcCtD
Cladribine—Ill-defined disorder—Prednisone—systemic lupus erythematosus	0.000156	0.000487	CcSEcCtD
Cladribine—Paraesthesia—Triamcinolone—systemic lupus erythematosus	0.000156	0.000487	CcSEcCtD
Cladribine—POLA1—DNA Replication—CDKN1B—systemic lupus erythematosus	0.000156	0.00138	CbGpPWpGaD
Cladribine—Feeling abnormal—Prednisolone—systemic lupus erythematosus	0.000156	0.000486	CcSEcCtD
Cladribine—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	0.000156	0.000486	CcSEcCtD
Cladribine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—systemic lupus erythematosus	0.000155	0.00137	CbGpPWpGaD
Cladribine—Anaemia—Prednisone—systemic lupus erythematosus	0.000155	0.000485	CcSEcCtD
Cladribine—Dyspnoea—Triamcinolone—systemic lupus erythematosus	0.000155	0.000484	CcSEcCtD
Cladribine—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.000154	0.000483	CcSEcCtD
Cladribine—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.000154	0.000483	CcSEcCtD
Cladribine—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	0.000154	0.000482	CcSEcCtD
Cladribine—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	0.000154	0.000482	CcSEcCtD
Cladribine—Tachycardia—Dexamethasone—systemic lupus erythematosus	0.000154	0.00048	CcSEcCtD
Cladribine—Tachycardia—Betamethasone—systemic lupus erythematosus	0.000154	0.00048	CcSEcCtD
Cladribine—POLA1—Synthesis of DNA—CDKN1A—systemic lupus erythematosus	0.000153	0.00135	CbGpPWpGaD
Cladribine—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.000153	0.000478	CcSEcCtD
Cladribine—Erythema multiforme—Methotrexate—systemic lupus erythematosus	0.000153	0.000477	CcSEcCtD
Cladribine—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	0.000152	0.000476	CcSEcCtD
Cladribine—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	0.000152	0.000476	CcSEcCtD
Cladribine—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	0.000152	0.000475	CcSEcCtD
Cladribine—Malaise—Prednisone—systemic lupus erythematosus	0.000152	0.000474	CcSEcCtD
Cladribine—Eye disorder—Methotrexate—systemic lupus erythematosus	0.000151	0.000471	CcSEcCtD
Cladribine—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	0.000151	0.000471	CcSEcCtD
Cladribine—Anorexia—Dexamethasone—systemic lupus erythematosus	0.00015	0.000469	CcSEcCtD
Cladribine—Anorexia—Betamethasone—systemic lupus erythematosus	0.00015	0.000469	CcSEcCtD
Cladribine—Urticaria—Prednisolone—systemic lupus erythematosus	0.00015	0.000469	CcSEcCtD
Cladribine—POLA1—G1/S Transition—CDKN1B—systemic lupus erythematosus	0.00015	0.00132	CbGpPWpGaD
Cladribine—Cardiac disorder—Methotrexate—systemic lupus erythematosus	0.00015	0.000468	CcSEcCtD
Cladribine—Fatigue—Triamcinolone—systemic lupus erythematosus	0.00015	0.000468	CcSEcCtD
Cladribine—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.000149	0.000467	CcSEcCtD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	0.000149	0.00132	CbGpPWpGaD
Cladribine—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.000149	0.000466	CcSEcCtD
Cladribine—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000149	0.000465	CcSEcCtD
Cladribine—Pain—Triamcinolone—systemic lupus erythematosus	0.000148	0.000464	CcSEcCtD
Cladribine—Hypotension—Betamethasone—systemic lupus erythematosus	0.000147	0.00046	CcSEcCtD
Cladribine—Hypotension—Dexamethasone—systemic lupus erythematosus	0.000147	0.00046	CcSEcCtD
Cladribine—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000147	0.000459	CcSEcCtD
Cladribine—NR5A1—Generic Transcription Pathway—PPARG—systemic lupus erythematosus	0.000147	0.0013	CbGpPWpGaD
Cladribine—Urticaria—Hydrocortisone—systemic lupus erythematosus	0.000146	0.000458	CcSEcCtD
Cladribine—Angiopathy—Methotrexate—systemic lupus erythematosus	0.000146	0.000458	CcSEcCtD
Cladribine—Immune system disorder—Methotrexate—systemic lupus erythematosus	0.000146	0.000455	CcSEcCtD
Cladribine—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.000146	0.000455	CcSEcCtD
Cladribine—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	0.000146	0.000455	CcSEcCtD
Cladribine—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	0.000145	0.000454	CcSEcCtD
Cladribine—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000145	0.000454	CcSEcCtD
Cladribine—Chills—Methotrexate—systemic lupus erythematosus	0.000145	0.000452	CcSEcCtD
Cladribine—POLA1—Cell Cycle—HIST2H2AC—systemic lupus erythematosus	0.000144	0.00127	CbGpPWpGaD
Cladribine—POLA1—DNA Replication—CDKN1A—systemic lupus erythematosus	0.000144	0.00127	CbGpPWpGaD
Cladribine—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	0.000144	0.000448	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	0.000144	0.000448	CcSEcCtD
Cladribine—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.000143	0.000447	CcSEcCtD
Cladribine—Myalgia—Prednisone—systemic lupus erythematosus	0.000143	0.000447	CcSEcCtD
Cladribine—Arthralgia—Prednisone—systemic lupus erythematosus	0.000143	0.000447	CcSEcCtD
Cladribine—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	0.000143	0.000447	CcSEcCtD
Cladribine—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	0.000143	0.000446	CcSEcCtD
Cladribine—Anxiety—Prednisone—systemic lupus erythematosus	0.000143	0.000446	CcSEcCtD
Cladribine—Alopecia—Methotrexate—systemic lupus erythematosus	0.000143	0.000446	CcSEcCtD
Cladribine—Insomnia—Dexamethasone—systemic lupus erythematosus	0.000142	0.000445	CcSEcCtD
Cladribine—Insomnia—Betamethasone—systemic lupus erythematosus	0.000142	0.000445	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.000142	0.000444	CcSEcCtD
Cladribine—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000142	0.000444	CcSEcCtD
Cladribine—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	0.000142	0.000443	CcSEcCtD
Cladribine—Paraesthesia—Betamethasone—systemic lupus erythematosus	0.000141	0.000442	CcSEcCtD
Cladribine—Paraesthesia—Dexamethasone—systemic lupus erythematosus	0.000141	0.000442	CcSEcCtD
Cladribine—Discomfort—Prednisone—systemic lupus erythematosus	0.000141	0.000442	CcSEcCtD
Cladribine—Mental disorder—Methotrexate—systemic lupus erythematosus	0.000141	0.000442	CcSEcCtD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	0.000141	0.00125	CbGpPWpGaD
Cladribine—Erythema—Methotrexate—systemic lupus erythematosus	0.00014	0.000439	CcSEcCtD
Cladribine—Malnutrition—Methotrexate—systemic lupus erythematosus	0.00014	0.000439	CcSEcCtD
Cladribine—Hypersensitivity—Prednisolone—systemic lupus erythematosus	0.000139	0.000435	CcSEcCtD
Cladribine—PNP—Levonorgestrel—Hydrocortisone—systemic lupus erythematosus	0.000139	0.0173	CbGdCrCtD
Cladribine—DCK—Desoximetasone—Hydrocortisone—systemic lupus erythematosus	0.000139	0.0173	CbGdCrCtD
Cladribine—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000138	0.000433	CcSEcCtD
Cladribine—POLA1—G1/S Transition—CDKN1A—systemic lupus erythematosus	0.000138	0.00122	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—PPARG—systemic lupus erythematosus	0.000138	0.00122	CbGpPWpGaD
Cladribine—Urticaria—Triamcinolone—systemic lupus erythematosus	0.000138	0.000431	CcSEcCtD
Cladribine—Urticaria—Methylprednisolone—systemic lupus erythematosus	0.000138	0.00043	CcSEcCtD
Cladribine—Body temperature increased—Triamcinolone—systemic lupus erythematosus	0.000137	0.000429	CcSEcCtD
Cladribine—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000137	0.000429	CcSEcCtD
Cladribine—Oedema—Prednisone—systemic lupus erythematosus	0.000137	0.000429	CcSEcCtD
Cladribine—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	0.000137	0.000428	CcSEcCtD
Cladribine—Decreased appetite—Dexamethasone—systemic lupus erythematosus	0.000137	0.000428	CcSEcCtD
Cladribine—Decreased appetite—Betamethasone—systemic lupus erythematosus	0.000137	0.000428	CcSEcCtD
Cladribine—Infection—Prednisone—systemic lupus erythematosus	0.000136	0.000426	CcSEcCtD
Cladribine—POLA1—S Phase—CDKN1B—systemic lupus erythematosus	0.000136	0.0012	CbGpPWpGaD
Cladribine—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.000136	0.000425	CcSEcCtD
Cladribine—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.000136	0.000425	CcSEcCtD
Cladribine—Back pain—Methotrexate—systemic lupus erythematosus	0.000136	0.000425	CcSEcCtD
Cladribine—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	0.000136	0.000424	CcSEcCtD
Cladribine—Fatigue—Betamethasone—systemic lupus erythematosus	0.000136	0.000424	CcSEcCtD
Cladribine—Fatigue—Dexamethasone—systemic lupus erythematosus	0.000136	0.000424	CcSEcCtD
Cladribine—RRM2B—Metabolism—RXRA—systemic lupus erythematosus	0.000135	0.00119	CbGpPWpGaD
Cladribine—Pain—Betamethasone—systemic lupus erythematosus	0.000135	0.000421	CcSEcCtD
Cladribine—Pain—Dexamethasone—systemic lupus erythematosus	0.000135	0.000421	CcSEcCtD
Cladribine—Nervous system disorder—Prednisone—systemic lupus erythematosus	0.000135	0.00042	CcSEcCtD
Cladribine—Tachycardia—Prednisone—systemic lupus erythematosus	0.000134	0.000418	CcSEcCtD
Cladribine—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000134	0.000418	CcSEcCtD
Cladribine—Skin disorder—Prednisone—systemic lupus erythematosus	0.000133	0.000416	CcSEcCtD
Cladribine—Hyperhidrosis—Prednisone—systemic lupus erythematosus	0.000133	0.000414	CcSEcCtD
Cladribine—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000132	0.000413	CcSEcCtD
Cladribine—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000132	0.000412	CcSEcCtD
Cladribine—Rash—Cyclosporine—systemic lupus erythematosus	0.000131	0.000409	CcSEcCtD
Cladribine—DCK—Desoximetasone—Methylprednisolone—systemic lupus erythematosus	0.000131	0.0164	CbGdCrCtD
Cladribine—Anorexia—Prednisone—systemic lupus erythematosus	0.000131	0.000409	CcSEcCtD
Cladribine—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000131	0.000408	CcSEcCtD
Cladribine—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.00013	0.000408	CcSEcCtD
Cladribine—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	0.00013	0.000407	CcSEcCtD
Cladribine—Headache—Cyclosporine—systemic lupus erythematosus	0.00013	0.000406	CcSEcCtD
Cladribine—Anaemia—Methotrexate—systemic lupus erythematosus	0.00013	0.000406	CcSEcCtD
Cladribine—Feeling abnormal—Betamethasone—systemic lupus erythematosus	0.00013	0.000406	CcSEcCtD
Cladribine—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	0.00013	0.000406	CcSEcCtD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	0.00013	0.00115	CbGpPWpGaD
Cladribine—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	0.000129	0.000403	CcSEcCtD
Cladribine—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	0.000129	0.000403	CcSEcCtD
Cladribine—DCK—Desoximetasone—Dexamethasone—systemic lupus erythematosus	0.000129	0.0161	CbGdCrCtD
Cladribine—DCK—Desoximetasone—Betamethasone—systemic lupus erythematosus	0.000129	0.0161	CbGdCrCtD
Cladribine—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000129	0.000402	CcSEcCtD
Cladribine—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	0.000128	0.0004	CcSEcCtD
Cladribine—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	0.000128	0.000399	CcSEcCtD
Cladribine—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.000128	0.000399	CcSEcCtD
Cladribine—NR5A1—Gene Expression—JUNB—systemic lupus erythematosus	0.000128	0.00113	CbGpPWpGaD
Cladribine—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000127	0.000398	CcSEcCtD
Cladribine—DCK—Diflorasone—Methylprednisolone—systemic lupus erythematosus	0.000127	0.0159	CbGdCrCtD
Cladribine—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000127	0.000396	CcSEcCtD
Cladribine—Malaise—Methotrexate—systemic lupus erythematosus	0.000127	0.000396	CcSEcCtD
Cladribine—POLA1—Mitotic G1-G1/S phases—CDKN1B—systemic lupus erythematosus	0.000126	0.00112	CbGpPWpGaD
Cladribine—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000126	0.000394	CcSEcCtD
Cladribine—DCK—Desoximetasone—Triamcinolone—systemic lupus erythematosus	0.000126	0.0157	CbGdCrCtD
Cladribine—POLA1—S Phase—CDKN1A—systemic lupus erythematosus	0.000126	0.00111	CbGpPWpGaD
Cladribine—Urticaria—Betamethasone—systemic lupus erythematosus	0.000125	0.000391	CcSEcCtD
Cladribine—Urticaria—Dexamethasone—systemic lupus erythematosus	0.000125	0.000391	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	0.000125	0.000391	CcSEcCtD
Cladribine—DCK—Diflorasone—Betamethasone—systemic lupus erythematosus	0.000125	0.0156	CbGdCrCtD
Cladribine—DCK—Diflorasone—Dexamethasone—systemic lupus erythematosus	0.000125	0.0156	CbGdCrCtD
Cladribine—Dizziness—Prednisolone—systemic lupus erythematosus	0.000125	0.00039	CcSEcCtD
Cladribine—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000125	0.000389	CcSEcCtD
Cladribine—Abdominal pain—Dexamethasone—systemic lupus erythematosus	0.000125	0.000389	CcSEcCtD
Cladribine—Abdominal pain—Betamethasone—systemic lupus erythematosus	0.000125	0.000389	CcSEcCtD
Cladribine—Body temperature increased—Betamethasone—systemic lupus erythematosus	0.000125	0.000389	CcSEcCtD
Cladribine—Body temperature increased—Dexamethasone—systemic lupus erythematosus	0.000125	0.000389	CcSEcCtD
Cladribine—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.000124	0.000388	CcSEcCtD
Cladribine—Insomnia—Prednisone—systemic lupus erythematosus	0.000124	0.000388	CcSEcCtD
Cladribine—Nausea—Cyclosporine—systemic lupus erythematosus	0.000123	0.000385	CcSEcCtD
Cladribine—Paraesthesia—Prednisone—systemic lupus erythematosus	0.000123	0.000385	CcSEcCtD
Cladribine—Pruritus—Triamcinolone—systemic lupus erythematosus	0.000123	0.000384	CcSEcCtD
Cladribine—Cough—Methotrexate—systemic lupus erythematosus	0.000123	0.000383	CcSEcCtD
Cladribine—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.000123	0.000383	CcSEcCtD
Cladribine—DCK—Diflorasone—Triamcinolone—systemic lupus erythematosus	0.000122	0.0153	CbGdCrCtD
Cladribine—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000122	0.000381	CcSEcCtD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	0.000121	0.00107	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—TYK2—systemic lupus erythematosus	0.000121	0.00107	CbGpPWpGaD
Cladribine—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.00012	0.000376	CcSEcCtD
Cladribine—RRM1—Metabolism—NAT2—systemic lupus erythematosus	0.00012	0.00106	CbGpPWpGaD
Cladribine—Myalgia—Methotrexate—systemic lupus erythematosus	0.00012	0.000374	CcSEcCtD
Cladribine—Chest pain—Methotrexate—systemic lupus erythematosus	0.00012	0.000374	CcSEcCtD
Cladribine—Arthralgia—Methotrexate—systemic lupus erythematosus	0.00012	0.000374	CcSEcCtD
Cladribine—DCK—Desoximetasone—Prednisone—systemic lupus erythematosus	0.000119	0.0149	CbGdCrCtD
Cladribine—Decreased appetite—Prednisone—systemic lupus erythematosus	0.000119	0.000373	CcSEcCtD
Cladribine—Rash—Prednisolone—systemic lupus erythematosus	0.000119	0.000372	CcSEcCtD
Cladribine—Dermatitis—Prednisolone—systemic lupus erythematosus	0.000119	0.000372	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	0.000119	0.000371	CcSEcCtD
Cladribine—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.000119	0.00037	CcSEcCtD
Cladribine—Fatigue—Prednisone—systemic lupus erythematosus	0.000118	0.00037	CcSEcCtD
Cladribine—Headache—Prednisolone—systemic lupus erythematosus	0.000118	0.00037	CcSEcCtD
Cladribine—Discomfort—Methotrexate—systemic lupus erythematosus	0.000118	0.000369	CcSEcCtD
Cladribine—Constipation—Prednisone—systemic lupus erythematosus	0.000117	0.000367	CcSEcCtD
Cladribine—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.000117	0.000366	CcSEcCtD
Cladribine—PNP—Metabolism—RXRA—systemic lupus erythematosus	0.000117	0.00103	CbGpPWpGaD
Cladribine—POLA1—Mitotic G1-G1/S phases—CDKN1A—systemic lupus erythematosus	0.000117	0.00103	CbGpPWpGaD
Cladribine—DCK—Desoximetasone—Prednisolone—systemic lupus erythematosus	0.000117	0.0146	CbGdCrCtD
Cladribine—Rash—Hydrocortisone—systemic lupus erythematosus	0.000116	0.000363	CcSEcCtD
Cladribine—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000116	0.000363	CcSEcCtD
Cladribine—DCK—Diflorasone—Prednisone—systemic lupus erythematosus	0.000116	0.0145	CbGdCrCtD
Cladribine—Confusional state—Methotrexate—systemic lupus erythematosus	0.000116	0.000361	CcSEcCtD
Cladribine—Headache—Hydrocortisone—systemic lupus erythematosus	0.000116	0.000361	CcSEcCtD
Cladribine—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000115	0.000359	CcSEcCtD
Cladribine—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000115	0.000358	CcSEcCtD
Cladribine—Infection—Methotrexate—systemic lupus erythematosus	0.000114	0.000356	CcSEcCtD
Cladribine—DCK—Diflorasone—Prednisolone—systemic lupus erythematosus	0.000113	0.0141	CbGdCrCtD
Cladribine—Feeling abnormal—Prednisone—systemic lupus erythematosus	0.000113	0.000353	CcSEcCtD
Cladribine—Asthenia—Dexamethasone—systemic lupus erythematosus	0.000113	0.000353	CcSEcCtD
Cladribine—Asthenia—Betamethasone—systemic lupus erythematosus	0.000113	0.000353	CcSEcCtD
Cladribine—Nervous system disorder—Methotrexate—systemic lupus erythematosus	0.000112	0.000351	CcSEcCtD
Cladribine—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	0.000112	0.000351	CcSEcCtD
Cladribine—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	0.000112	0.000351	CcSEcCtD
Cladribine—Nausea—Prednisolone—systemic lupus erythematosus	0.000112	0.00035	CcSEcCtD
Cladribine—NR5A1—Gene Expression—RXRA—systemic lupus erythematosus	0.000112	0.000988	CbGpPWpGaD
Cladribine—Pruritus—Dexamethasone—systemic lupus erythematosus	0.000111	0.000348	CcSEcCtD
Cladribine—Pruritus—Betamethasone—systemic lupus erythematosus	0.000111	0.000348	CcSEcCtD
Cladribine—Skin disorder—Methotrexate—systemic lupus erythematosus	0.000111	0.000348	CcSEcCtD
Cladribine—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	0.000111	0.000346	CcSEcCtD
Cladribine—Vomiting—Triamcinolone—systemic lupus erythematosus	0.00011	0.000345	CcSEcCtD
Cladribine—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.00011	0.000344	CcSEcCtD
Cladribine—Nausea—Hydrocortisone—systemic lupus erythematosus	0.00011	0.000342	CcSEcCtD
Cladribine—Rash—Triamcinolone—systemic lupus erythematosus	0.000109	0.000342	CcSEcCtD
Cladribine—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.000109	0.000342	CcSEcCtD
Cladribine—Anorexia—Methotrexate—systemic lupus erythematosus	0.000109	0.000342	CcSEcCtD
Cladribine—Rash—Methylprednisolone—systemic lupus erythematosus	0.000109	0.000341	CcSEcCtD
Cladribine—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.000109	0.000341	CcSEcCtD
Cladribine—Urticaria—Prednisone—systemic lupus erythematosus	0.000109	0.000341	CcSEcCtD
Cladribine—Headache—Triamcinolone—systemic lupus erythematosus	0.000109	0.00034	CcSEcCtD
Cladribine—Headache—Methylprednisolone—systemic lupus erythematosus	0.000109	0.000339	CcSEcCtD
Cladribine—Abdominal pain—Prednisone—systemic lupus erythematosus	0.000108	0.000339	CcSEcCtD
Cladribine—Body temperature increased—Prednisone—systemic lupus erythematosus	0.000108	0.000339	CcSEcCtD
Cladribine—Diarrhoea—Betamethasone—systemic lupus erythematosus	0.000108	0.000337	CcSEcCtD
Cladribine—Diarrhoea—Dexamethasone—systemic lupus erythematosus	0.000108	0.000337	CcSEcCtD
Cladribine—ABCG2—HIF-1-alpha transcription factor network—EP300—systemic lupus erythematosus	0.000108	0.00095	CbGpPWpGaD
Cladribine—Hypotension—Methotrexate—systemic lupus erythematosus	0.000107	0.000335	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	0.000104	0.000326	CcSEcCtD
Cladribine—Dizziness—Dexamethasone—systemic lupus erythematosus	0.000104	0.000326	CcSEcCtD
Cladribine—Dizziness—Betamethasone—systemic lupus erythematosus	0.000104	0.000326	CcSEcCtD
Cladribine—Insomnia—Methotrexate—systemic lupus erythematosus	0.000104	0.000324	CcSEcCtD
Cladribine—Nausea—Triamcinolone—systemic lupus erythematosus	0.000103	0.000322	CcSEcCtD
Cladribine—Paraesthesia—Methotrexate—systemic lupus erythematosus	0.000103	0.000322	CcSEcCtD
Cladribine—Nausea—Methylprednisolone—systemic lupus erythematosus	0.000103	0.000322	CcSEcCtD
Cladribine—Dyspnoea—Methotrexate—systemic lupus erythematosus	0.000102	0.000319	CcSEcCtD
Cladribine—Somnolence—Methotrexate—systemic lupus erythematosus	0.000102	0.000319	CcSEcCtD
Cladribine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—systemic lupus erythematosus	0.000102	0.0009	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—VDR—systemic lupus erythematosus	0.000101	0.000895	CbGpPWpGaD
Cladribine—Hypersensitivity—Prednisone—systemic lupus erythematosus	0.000101	0.000316	CcSEcCtD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	0.000101	0.000893	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle, Mitotic—CDKN1B—systemic lupus erythematosus	0.000101	0.000892	CbGpPWpGaD
Cladribine—Vomiting—Betamethasone—systemic lupus erythematosus	0.0001	0.000313	CcSEcCtD
Cladribine—Vomiting—Dexamethasone—systemic lupus erythematosus	0.0001	0.000313	CcSEcCtD
Cladribine—SLC28A3—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	9.99e-05	0.000883	CbGpPWpGaD
Cladribine—Decreased appetite—Methotrexate—systemic lupus erythematosus	9.97e-05	0.000311	CcSEcCtD
Cladribine—Rash—Betamethasone—systemic lupus erythematosus	9.93e-05	0.00031	CcSEcCtD
Cladribine—Rash—Dexamethasone—systemic lupus erythematosus	9.93e-05	0.00031	CcSEcCtD
Cladribine—Dermatitis—Betamethasone—systemic lupus erythematosus	9.92e-05	0.00031	CcSEcCtD
Cladribine—Dermatitis—Dexamethasone—systemic lupus erythematosus	9.92e-05	0.00031	CcSEcCtD
Cladribine—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	9.9e-05	0.000309	CcSEcCtD
Cladribine—Fatigue—Methotrexate—systemic lupus erythematosus	9.89e-05	0.000309	CcSEcCtD
Cladribine—Headache—Betamethasone—systemic lupus erythematosus	9.87e-05	0.000308	CcSEcCtD
Cladribine—Headache—Dexamethasone—systemic lupus erythematosus	9.87e-05	0.000308	CcSEcCtD
Cladribine—RRM2—Metabolism—NAT2—systemic lupus erythematosus	9.87e-05	0.000872	CbGpPWpGaD
Cladribine—Asthenia—Prednisone—systemic lupus erythematosus	9.84e-05	0.000308	CcSEcCtD
Cladribine—Pain—Methotrexate—systemic lupus erythematosus	9.8e-05	0.000306	CcSEcCtD
Cladribine—Pruritus—Prednisone—systemic lupus erythematosus	9.71e-05	0.000303	CcSEcCtD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	9.57e-05	0.000846	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—MMP9—systemic lupus erythematosus	9.52e-05	0.000841	CbGpPWpGaD
Cladribine—Feeling abnormal—Methotrexate—systemic lupus erythematosus	9.45e-05	0.000295	CcSEcCtD
Cladribine—Diarrhoea—Prednisone—systemic lupus erythematosus	9.39e-05	0.000293	CcSEcCtD
Cladribine—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	9.38e-05	0.000293	CcSEcCtD
Cladribine—Nausea—Betamethasone—systemic lupus erythematosus	9.36e-05	0.000292	CcSEcCtD
Cladribine—Nausea—Dexamethasone—systemic lupus erythematosus	9.36e-05	0.000292	CcSEcCtD
Cladribine—POLE2—Cell Cycle, Mitotic—CDKN1A—systemic lupus erythematosus	9.31e-05	0.000823	CbGpPWpGaD
Cladribine—DCK—Metabolism—NAT2—systemic lupus erythematosus	9.22e-05	0.000815	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—NR3C1—systemic lupus erythematosus	9.11e-05	0.000805	CbGpPWpGaD
Cladribine—Urticaria—Methotrexate—systemic lupus erythematosus	9.11e-05	0.000285	CcSEcCtD
Cladribine—Dizziness—Prednisone—systemic lupus erythematosus	9.07e-05	0.000283	CcSEcCtD
Cladribine—Abdominal pain—Methotrexate—systemic lupus erythematosus	9.06e-05	0.000283	CcSEcCtD
Cladribine—Body temperature increased—Methotrexate—systemic lupus erythematosus	9.06e-05	0.000283	CcSEcCtD
Cladribine—NR5A1—Developmental Biology—EP300—systemic lupus erythematosus	9.03e-05	0.000798	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—CDKN1B—systemic lupus erythematosus	9.02e-05	0.000797	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle, Mitotic—EP300—systemic lupus erythematosus	8.86e-05	0.000783	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	8.83e-05	0.00078	CbGpPWpGaD
Cladribine—Vomiting—Prednisone—systemic lupus erythematosus	8.72e-05	0.000273	CcSEcCtD
Cladribine—Rash—Prednisone—systemic lupus erythematosus	8.65e-05	0.00027	CcSEcCtD
Cladribine—Dermatitis—Prednisone—systemic lupus erythematosus	8.64e-05	0.00027	CcSEcCtD
Cladribine—Headache—Prednisone—systemic lupus erythematosus	8.59e-05	0.000269	CcSEcCtD
Cladribine—NR5A1—Developmental Biology—VEGFA—systemic lupus erythematosus	8.55e-05	0.000756	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—PPARG—systemic lupus erythematosus	8.52e-05	0.000753	CbGpPWpGaD
Cladribine—Hypersensitivity—Methotrexate—systemic lupus erythematosus	8.45e-05	0.000264	CcSEcCtD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	8.41e-05	0.000743	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—CDKN1A—systemic lupus erythematosus	8.33e-05	0.000736	CbGpPWpGaD
Cladribine—Asthenia—Methotrexate—systemic lupus erythematosus	8.23e-05	0.000257	CcSEcCtD
Cladribine—Nausea—Prednisone—systemic lupus erythematosus	8.15e-05	0.000255	CcSEcCtD
Cladribine—Pruritus—Methotrexate—systemic lupus erythematosus	8.11e-05	0.000253	CcSEcCtD
Cladribine—DCK—Levonorgestrel—Hydrocortisone—systemic lupus erythematosus	8.1e-05	0.0101	CbGdCrCtD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	7.96e-05	0.000703	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—EP300—systemic lupus erythematosus	7.92e-05	0.0007	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—TGFB1—systemic lupus erythematosus	7.85e-05	0.000693	CbGpPWpGaD
Cladribine—Diarrhoea—Methotrexate—systemic lupus erythematosus	7.85e-05	0.000245	CcSEcCtD
Cladribine—RRM2B—Metabolism—ALB—systemic lupus erythematosus	7.66e-05	0.000677	CbGpPWpGaD
Cladribine—Dizziness—Methotrexate—systemic lupus erythematosus	7.58e-05	0.000237	CcSEcCtD
Cladribine—PNP—Metabolism—PPARG—systemic lupus erythematosus	7.39e-05	0.000652	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—TNF—systemic lupus erythematosus	7.33e-05	0.000647	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—NOS3—systemic lupus erythematosus	7.33e-05	0.000647	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	7.31e-05	0.000646	CbGpPWpGaD
Cladribine—Vomiting—Methotrexate—systemic lupus erythematosus	7.29e-05	0.000228	CcSEcCtD
Cladribine—Rash—Methotrexate—systemic lupus erythematosus	7.23e-05	0.000226	CcSEcCtD
Cladribine—Dermatitis—Methotrexate—systemic lupus erythematosus	7.22e-05	0.000226	CcSEcCtD
Cladribine—Headache—Methotrexate—systemic lupus erythematosus	7.18e-05	0.000224	CcSEcCtD
Cladribine—NR5A1—Gene Expression—PPARG—systemic lupus erythematosus	7.06e-05	0.000624	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	6.82e-05	0.000603	CbGpPWpGaD
Cladribine—Nausea—Methotrexate—systemic lupus erythematosus	6.81e-05	0.000213	CcSEcCtD
Cladribine—RRM2—Cell Cycle, Mitotic—CDKN1B—systemic lupus erythematosus	6.77e-05	0.000599	CbGpPWpGaD
Cladribine—RRM1—Metabolism—RXRA—systemic lupus erythematosus	6.72e-05	0.000594	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—PTGS2—systemic lupus erythematosus	6.7e-05	0.000592	CbGpPWpGaD
Cladribine—PNP—Metabolism—ALB—systemic lupus erythematosus	6.64e-05	0.000587	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—CDKN1B—systemic lupus erythematosus	6.5e-05	0.000575	CbGpPWpGaD
Cladribine—PNP—Metabolism—NOS3—systemic lupus erythematosus	6.35e-05	0.000561	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—CDKN1A—systemic lupus erythematosus	6.25e-05	0.000552	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—CDKN1B—systemic lupus erythematosus	6.06e-05	0.000535	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—CDKN1A—systemic lupus erythematosus	6e-05	0.00053	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—EP300—systemic lupus erythematosus	5.95e-05	0.000526	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—IL6—systemic lupus erythematosus	5.91e-05	0.000523	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—CDKN1B—systemic lupus erythematosus	5.81e-05	0.000514	CbGpPWpGaD
Cladribine—PNP—Metabolism—PTGS2—systemic lupus erythematosus	5.81e-05	0.000513	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—EP300—systemic lupus erythematosus	5.71e-05	0.000505	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—CDKN1A—systemic lupus erythematosus	5.59e-05	0.000494	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—EP300—systemic lupus erythematosus	5.57e-05	0.000492	CbGpPWpGaD
Cladribine—RRM2—Metabolism—RXRA—systemic lupus erythematosus	5.53e-05	0.000489	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—CDKN1A—systemic lupus erythematosus	5.37e-05	0.000474	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—EP300—systemic lupus erythematosus	5.32e-05	0.00047	CbGpPWpGaD
Cladribine—DCK—Metabolism—RXRA—systemic lupus erythematosus	5.17e-05	0.000457	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—EP300—systemic lupus erythematosus	5.11e-05	0.000451	CbGpPWpGaD
Cladribine—SLC22A2—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	4.88e-05	0.000432	CbGpPWpGaD
Cladribine—PNP—Metabolism—EP300—systemic lupus erythematosus	4.83e-05	0.000427	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—CDKN1B—systemic lupus erythematosus	4.63e-05	0.000409	CbGpPWpGaD
Cladribine—SLC22A1—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	4.55e-05	0.000402	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	4.42e-05	0.00039	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	4.37e-05	0.000386	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—CDKN1A—systemic lupus erythematosus	4.28e-05	0.000378	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PPARG—systemic lupus erythematosus	4.24e-05	0.000375	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—CDKN1B—systemic lupus erythematosus	4.14e-05	0.000366	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	4.07e-05	0.00036	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—EP300—systemic lupus erythematosus	4.07e-05	0.000359	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—CDKN1A—systemic lupus erythematosus	3.82e-05	0.000338	CbGpPWpGaD
Cladribine—RRM1—Metabolism—ALB—systemic lupus erythematosus	3.81e-05	0.000337	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—NAT2—systemic lupus erythematosus	3.69e-05	0.000326	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—NAT2—systemic lupus erythematosus	3.65e-05	0.000323	CbGpPWpGaD
Cladribine—RRM1—Metabolism—NOS3—systemic lupus erythematosus	3.65e-05	0.000322	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—EP300—systemic lupus erythematosus	3.64e-05	0.000321	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PPARG—systemic lupus erythematosus	3.49e-05	0.000309	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—NAT2—systemic lupus erythematosus	3.4e-05	0.000301	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PTGS2—systemic lupus erythematosus	3.34e-05	0.000295	CbGpPWpGaD
Cladribine—DCK—Metabolism—PPARG—systemic lupus erythematosus	3.26e-05	0.000288	CbGpPWpGaD
Cladribine—RRM2—Metabolism—ALB—systemic lupus erythematosus	3.14e-05	0.000277	CbGpPWpGaD
Cladribine—RRM2—Metabolism—NOS3—systemic lupus erythematosus	3e-05	0.000265	CbGpPWpGaD
Cladribine—DCK—Metabolism—ALB—systemic lupus erythematosus	2.93e-05	0.000259	CbGpPWpGaD
Cladribine—DCK—Metabolism—NOS3—systemic lupus erythematosus	2.81e-05	0.000248	CbGpPWpGaD
Cladribine—RRM1—Metabolism—EP300—systemic lupus erythematosus	2.78e-05	0.000245	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PTGS2—systemic lupus erythematosus	2.75e-05	0.000243	CbGpPWpGaD
Cladribine—DCK—Metabolism—PTGS2—systemic lupus erythematosus	2.57e-05	0.000227	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	2.51e-05	0.000222	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	2.48e-05	0.000219	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	2.31e-05	0.000204	CbGpPWpGaD
Cladribine—RRM2—Metabolism—EP300—systemic lupus erythematosus	2.29e-05	0.000202	CbGpPWpGaD
Cladribine—DCK—Metabolism—EP300—systemic lupus erythematosus	2.14e-05	0.000189	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—RXRA—systemic lupus erythematosus	2.07e-05	0.000183	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—RXRA—systemic lupus erythematosus	2.05e-05	0.000181	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—RXRA—systemic lupus erythematosus	1.91e-05	0.000169	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PPARG—systemic lupus erythematosus	1.31e-05	0.000115	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PPARG—systemic lupus erythematosus	1.29e-05	0.000114	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PPARG—systemic lupus erythematosus	1.2e-05	0.000106	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—ALB—systemic lupus erythematosus	1.17e-05	0.000104	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—ALB—systemic lupus erythematosus	1.16e-05	0.000103	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—NOS3—systemic lupus erythematosus	1.12e-05	9.93e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—NOS3—systemic lupus erythematosus	1.11e-05	9.82e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—ALB—systemic lupus erythematosus	1.08e-05	9.57e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—NOS3—systemic lupus erythematosus	1.04e-05	9.16e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PTGS2—systemic lupus erythematosus	1.03e-05	9.08e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PTGS2—systemic lupus erythematosus	1.02e-05	8.98e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PTGS2—systemic lupus erythematosus	9.48e-06	8.37e-05	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—EP300—systemic lupus erythematosus	8.55e-06	7.55e-05	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—EP300—systemic lupus erythematosus	8.46e-06	7.47e-05	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—EP300—systemic lupus erythematosus	7.88e-06	6.97e-05	CbGpPWpGaD
